Pediatric Pulmonology 2023 year in review: Rare and diffuse lung disease

Pediatr Pulmonol. 2024 Oct;59(10):2428-2434. doi: 10.1002/ppul.27108. Epub 2024 May 31.

Abstract

The field of pediatric rare and diffuse lung disease continues its maturation as research advances the understanding of diagnosis and treatment of children's interstitial lung disease, noncystic fibrosis bronchiectasis, and primary ciliary dyskinesia. The rarity and breadth of these conditions make them challenging to study, yet we continue to make progress in our understanding of pathophysiology, genotype/phenotype relationships, and treatment. Papers published on these topics in Pediatric Pulmonology and other journals in 2023 describe the power of multicenter cooperation and patient registries, enhance our understanding of pathophysiology and genotype/phenotype relationships, and report progress in treatments. In this review, we hope to increase awareness and knowledge of these conditions and to inspire future research.

Keywords: bronchiectasis; interstitial lung disease; primary ciliary dyskinesia.

Publication types

  • Review

MeSH terms

  • Bronchiectasis / diagnosis
  • Bronchiectasis / physiopathology
  • Bronchiectasis / therapy
  • Child
  • Humans
  • Lung Diseases / diagnosis
  • Lung Diseases / physiopathology
  • Lung Diseases / therapy
  • Lung Diseases, Interstitial / diagnosis
  • Lung Diseases, Interstitial / physiopathology
  • Lung Diseases, Interstitial / therapy
  • Pediatrics
  • Pulmonary Medicine*
  • Rare Diseases / therapy

Grants and funding